2019 CMHC Annual - Virtual Exhibit Hall
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Vascepa® (icosapent ethyl), Amarin's first FDA approved product, is a pure, EPA-only, omega-3 fatty acid product available by prescription. For more information about Vascepa visit www.vascepa.com. For more information visit www.amarincorp.com.
Founded in 1985, the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) is dedicated to our mission of reducing morbidity, mortality and disability from cardiovascular and pulmonary disease through education, prevention, rehabilitation, research and disease management. Central to the core mission is improvement in quality of life for patients and their families. We are a multidisciplinary professional association comprised of health professionals who serve in the field of cardiac and pulmonary rehabilitation. Members include cardiovascular and pulmonary physicians, nurses, exercise physiologists, physical therapists, behavioral scientists, respiratory therapists, dietitians and nutritionists.
Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA welcome you to Cardiometabolic Health Congress and look forward to the opportunity to share the latest clinical information on our products. Visit http://us.boehringer-ingelheim.com or www.lilly.com. Follow us on twitter at @boehringerus. Our Diabetes Alliance also welcomes you to visit www.jardiance.com.
The Quest Diagnostics-Cleveland HeartLab Cardiometabolic Center of Excellence is committed to advancing the prevention of the most costly and debilitating cardiovascular events. Our broadly available comprehensive menu of novel biomarkers spanning the cardiometabolic continuum provides deeper insights into hidden risk that go well beyond traditional testing. By combining this enhanced diagnostic capability with solutions to help engage patients in their care, we empower people to take action to reduce cardiometabolic risk, while improving long-term health outcomes.
Daiichi Sankyo, Inc., headquartered in Basking Ridge, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd. Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo Group and is focused on the development of oncology therapies and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for hypertension, pain management, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma.
CARDIOLOGY TODAY AND ENDOCRINE TODAY are reporting LIVE at CMHC! In print and online, you’ll get the latest meeting coverage along with expert perspective from our renowned Editorial Boards and other leading clinicians. Explore videos, In the Journals and resources that are relevant to your practice. Stop by our booth for a free issue of Cardiology Today and Endocrine Today.
For more than a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, Merck continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
Medicure is a pharmaceutical company focused on the development and commercialization of cardiovascular therapeutics for the U.S. market. Medicure strives to become a leading specialty pharmaceutical company in the U.S. market by improving people’s lives through our growing product portfolio of acute cardiovascular products and innovative commercial model. Our commitment to service, partnership and integrity are what sets us apart.
Med Learning Group focuses on developing and implementing education that improves healthcare practitioners’ ability to provide optimal care to patients. Visit MLG at Booth 204 to be taken through a Virtual Reality tour of hypercholesterolemia. The VR learning booth includes three Virtual Reality themes, a case study on iPads, Quality Improvement Personalized Posters, Augmented Reality and downloadable clinical practice animations.
Novo Nordisk, a global leader in diabetes care, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. We’re working toward a future where fewer people get diabetes, everyone is diagnosed, and all patients receive adequate treatment.
SpectraCell Laboratories, Inc. is a leading clinical laboratory specializing in personalized disease prevention and management solutions. Our pioneering nutritional and cardiometabolic testing, driven by state-of-the-art technology, assesses a spectrum of risk factors and biomarkers for optimum wellness. Through our dedication to research and development, SpectraCell also provides innovative solutions for hormone health and genetics. We are committed to providing scientific excellence, superior disease prevention and management solutions, and the highest quality of service to clients and their patients worldwide.
Patient Advocate Foundation provides direct services to patients with chronic, life threatening and debilitating diseases to help eliminate obstacles in access to quality healthcare. A comprehensive portfolio delivers educational, financial and insurance resources, featuring Matters of the Heart is available in one easy-to-access online location.